EP1979327 - PYRIDINE AND PYRIMIDINE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE [Right-click to bookmark this link] | Status | The application has been refused Status updated on 01.11.2013 Database last updated on 05.07.2024 | Most recent event Tooltip | 01.11.2013 | Refusal of application | published on 04.12.2013 [2013/49] | Applicant(s) | For all designated states Janssen Pharmaceutica N.V. Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
Former [2008/42] | For all designated states Janssen Pharmaceutica, N.V. Turnhoutseweg 30 2340 Beerse / BE | Inventor(s) | 01 /
ANGIBAUD, Patrick, René Johnson & Johnson Pharmaceutical Research and Development; Division of Janssen-Cilag Campus De Maigremont BP 615 F-27106 Val de Reuil Cedex / FR | 02 /
MARCONNET-DECRANE, Laurence, Françoise, Bernadette Johnson & Johnson Pharmaceutical Research and Development; Division of Janssen-Cilag Campus De Maigremont BP 615 F-27106 Val de Reuil Cedex / FR | 03 /
ARTS, Janine Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 Beerse / BE | [2008/42] | Representative(s) | Vandersteen, Pieter Johnson & Johnson Patent Law Department Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
Former [2008/42] | Vandersteen, Pieter Janssen Pharmaceutica N.V. Turnhoutseweg 30 2340 Beerse / BE | Application number, filing date | 07703889.1 | 16.01.2007 | [2008/42] | WO2007EP50374 | Priority number, date | EP20060100575 | 19.01.2006 Original published format: EP 06100575 | [2008/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007082876 | Date: | 26.07.2007 | Language: | EN | [2007/30] | Type: | A1 Application with search report | No.: | EP1979327 | Date: | 15.10.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.07.2007 takes the place of the publication of the European patent application. | [2008/42] | Search report(s) | International search report - published on: | EP | 26.07.2007 | Classification | IPC: | C07D239/42, C07D213/82, C07D409/10, A61K31/506, A61P35/00 | [2008/42] | CPC: |
C07D213/82 (EP,US);
A61P1/04 (EP);
A61P11/06 (EP);
A61P11/08 (EP);
A61P13/12 (EP);
A61P15/08 (EP);
A61P17/00 (EP);
A61P17/10 (EP);
A61P17/14 (EP);
A61P19/02 (EP);
A61P19/06 (EP);
A61P19/08 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/18 (EP);
A61P33/06 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P9/04 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/42] | Extension states | AL | 19.08.2008 | BA | 19.08.2008 | HR | 19.08.2008 | MK | 19.08.2008 | RS | 19.08.2008 | Title | German: | PYRIDIN- UND PYRIMIDINDERIVATE ALS INHIBITOREN VON HISTONDEACETYLASE | [2008/42] | English: | PYRIDINE AND PYRIMIDINE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE | [2008/42] | French: | DÉRIVÉS DE PYRIDINE ET DE PYRIMIDINE EN TANT QU'INHIBITEURS D'HISTONE DÉSACÉTYLASE | [2008/42] | Entry into regional phase | 19.08.2008 | National basic fee paid | 19.08.2008 | Designation fee(s) paid | 15.07.2008 | Examination fee paid | Examination procedure | 15.07.2008 | Examination requested [2008/42] | 21.07.2010 | Despatch of a communication from the examining division (Time limit: M06) | 24.01.2011 | Reply to a communication from the examining division | 27.06.2011 | Despatch of a communication from the examining division (Time limit: M06) | 23.12.2011 | Reply to a communication from the examining division | 13.02.2013 | Cancellation of oral proceeding that was planned for 15.03.2013 | 15.03.2013 | Date of oral proceedings (cancelled) | 17.07.2013 | Despatch of communication that the application is refused, reason: substantive examination [2013/49] | 27.07.2013 | Application refused, date of legal effect [2013/49] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.07.2010 | Fees paid | Renewal fee | 02.02.2009 | Renewal fee patent year 03 | 01.02.2010 | Renewal fee patent year 04 | 31.01.2011 | Renewal fee patent year 05 | 31.01.2012 | Renewal fee patent year 06 | 31.01.2013 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DY]WO03075929 (JANSSEN PHARMACEUTICA NV [BE], et al) [DY] 1-10* the whole document *; | [DY]WO03092686 (ASTRAZENECA AB [SE], et al) [DY] 1-10 * the whole document *; | [DY]WO2005030705 (METHYLGENE INC [CA], et al) [DY] 1-10 * the whole document *; | [PA]WO2006010749 (JANSSEN PHARMACEUTICA NV [BE], et al) [PA] 1-10 * the whole document * |